COVID-19 and Long-Term Outcomes: Lessons from Other Critical Care Illnesses and Potential Mechanisms
Open Access
- 1 September 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 67 (3) , 275-283
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that is currently causing a pandemic and has been termed coronavirus disease (COVID-19). The elderly or those with preexisting conditions like diabetes, hypertension, coronary heart disease, chronic obstructive pulmonary disease, cerebrovascular disease, or kidney dysfunction are more likely to develop severe cases when infected. Patients with COVID-19 admitted to the ICU have higher mortality than non-ICU patients. Critical illness has consistently posed a challenge not only in terms of mortality but also in regard to long-term outcomes of survivors. Patients who survive acute critical illness including, but not limited to, pulmonary and systemic insults associated with acute respiratory distress syndrome, pneumonia, systemic inflammation, and mechanical ventilation, will likely suffer from post-ICU syndrome, a phenomenon of cognitive, psychiatric, and/or physical disability after treatment in the ICU. Post-ICU morbidity and mortality continue to be a cause for concern when considering large-scale studies showing 12-month mortality risks of 11.8–21%. Previous studies have demonstrated that multiple mechanisms, including cytokine release, mitochondrial dysfunction, and even amyloids, may lead to end-organ dysfunction in patients. We hypothesize that COVID-19 infection will lead to post-ICU syndrome via potentially similar mechanisms as other chronic critical illnesses and cause long-term morbidity and mortality in patients. We consider a variety of mechanisms and questions that not only consider the short-term impact of the COVID-19 pandemic but its long-term effects that may not yet be imagined.Keywords
Funding Information
- National Institute of General Medical Sciences (R01GM127584)
- National Heart, Lung, and Blood Institute (P01HL066299)
- National Institute of General Medical Sciences (R01GM127584)
- National Heart, Lung, and Blood Institute (P01HL066299)
This publication has 73 references indexed in Scilit:
- Cognitive decline after sepsisThe Lancet Respiratory Medicine, 2015
- The role of mitochondrial dysfunction in sepsis-induced multi-organ failureVirulence, 2013
- Pseudomonas aeruginosa Exotoxin Y-Mediated Tau Hyperphosphorylation Impairs Microtubule Assembly in Pulmonary Microvascular Endothelial CellsPLOS ONE, 2013
- High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in AsiaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive declineProceedings of the National Academy of Sciences, 2010
- The long‐term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health statusRespirology, 2010
- Mitochondria, endoplasmic reticulum, and alternative pathways of cell death in critical illnessCritical Care Medicine, 2007
- Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammationThe Lancet, 2004
- Surviving Pneumonia—Just a Short-Term Lease on Life?American Journal of Respiratory and Critical Care Medicine, 2004
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001